These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15157880)

  • 1. Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.
    Blencke S; Zech B; Engkvist O; Greff Z; Orfi L; Horváth Z; Kéri G; Ullrich A; Daub H
    Chem Biol; 2004 May; 11(5):691-701. PubMed ID: 15157880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
    Verkhivker GM
    Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for selective inhibition of Src family kinases by PP1.
    Liu Y; Bishop A; Witucki L; Kraybill B; Shimizu E; Tsien J; Ubersax J; Blethrow J; Morgan DO; Shokat KM
    Chem Biol; 1999 Sep; 6(9):671-8. PubMed ID: 10467133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives.
    Caballero J; Fernández M; Saavedra M; González-Nilo FD
    Bioorg Med Chem; 2008 Jan; 16(2):810-21. PubMed ID: 17964795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of irreversible kinase inhibitors by directly detecting covalent bond formation: a tool for dissecting kinase drug resistance.
    Klüter S; Simard JR; Rode HB; Grütter C; Pawar V; Raaijmakers HC; Barf TA; Rabiller M; van Otterlo WA; Rauh D
    Chembiochem; 2010 Dec; 11(18):2557-66. PubMed ID: 21080395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles of protein tyrosine kinase genes in human embryonic stem cells.
    Son MY; Kim J; Han HW; Woo SM; Cho YS; Kang YK; Han YM
    Reproduction; 2008 Oct; 136(4):423-32. PubMed ID: 18583472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor association and tyrosine phosphorylation of S6 kinases.
    Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
    FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling.
    Gunby RH; Ahmed S; Sottocornola R; Gasser M; Redaelli S; Mologni L; Tartari CJ; Belloni V; Gambacorti-Passerini C; Scapozza L
    J Med Chem; 2006 Sep; 49(19):5759-68. PubMed ID: 16970400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
    Chen KC; Zhou Y; Zhang W; Lou MF
    Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico profiling of tyrosine kinases binding specificity and drug resistance using Monte Carlo simulations with the ensembles of protein kinase crystal structures.
    Verkhivker GM
    Biopolymers; 2007 Mar; 85(4):333-48. PubMed ID: 17167796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
    Wang CY; Wang YT; Tzeng DW; Yang JL
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine compounds as inhibitors of the src protein tyrosine kinase: screening of a combinatorial library of 1,4-benzodiazepines.
    Ramdas L; Bunnin BA; Plunkett MJ; Sun G; Ellman J; Gallick G; Budde RJ
    Arch Biochem Biophys; 1999 Aug; 368(2):394-400. PubMed ID: 10441393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes.
    Kansra S; Stoll SW; Johnson JL; Elder JT
    Mol Pharmacol; 2005 Apr; 67(4):1145-57. PubMed ID: 15615697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general framework for inhibitor resistance in protein kinases.
    Balzano D; Santaguida S; Musacchio A; Villa F
    Chem Biol; 2011 Aug; 18(8):966-75. PubMed ID: 21867912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical chemistry and molecular mechanisms of tyrosine kinase inhibitors. The viewpoint of pharmaceutical research].
    Holm M; Lehmann F; Laufer S
    Pharm Unserer Zeit; 2008; 37(5):382-92. PubMed ID: 18729263
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequence survey of receptor tyrosine kinases reveals mutations in glioblastomas.
    Rand V; Huang J; Stockwell T; Ferriera S; Buzko O; Levy S; Busam D; Li K; Edwards JB; Eberhart C; Murphy KM; Tsiamouri A; Beeson K; Simpson AJ; Venter JC; Riggins GJ; Strausberg RL
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14344-9. PubMed ID: 16186508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases.
    Backlund M; Ingelman-Sundberg M
    Cell Signal; 2005 Jan; 17(1):39-48. PubMed ID: 15451023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.